1 completed, 1 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Terminated 1 |
Follow Insulin Secretion: new trials by email Literature Review of Insulin Secretion trials Research Report on Insulin Secretion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Regulation of Insulin Secretion by the GLP-1 Receptor Exendin (9-39), Dexamethasone, Hyperglycemic Clamp - Insulin Secretion | Phase 4 | Terminated | VA Office of Research and Development | 6 | 2018-07-01 | 2024-12-12 |
| Contribution of Pancreatic αcells Function to Blood Glucose Regulation in Chinese Type 2 Diabetics- the Effect of Sitagliptin on Glucagon Secretion, Insulin Secretion and Insulin Resistance in Chinese Type 2 Diabetics Sitagliptin - Insulin Secretion, Insulin Resistance | Phase 4 | Completed | Guangwei Li | 85 | 2012-10-01 | 2017-05-11 |
Insulin Resistance (2) · Diabetes Mellitus (1) · Glucose Intolerance (1)
Glucose Metabolism Disorders (2) · Hyperinsulinism (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Endocrine System Diseases (1) · Hyperglycemia (1)
Dexamethasone (1) · Sitagliptin Phosphate (1) · exendin (9-39) (1)
Guangwei Li (1) · VA Office of Research and Development (1)
China (1) · United States (1)